This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
S&P Indices and the Indexing Business in 2012
Viceira, Luis M.; Wagonfeld, Alison BerkleyCase HBS-213049-EFinanceIn June 2012, Standard & Poor's Indices is finalizing a deal with the CME Group, the largest global exchange for futures and options and majority owner of Dow Jones Indexes, to combine their respective indices business into a new joint venture called S&P Dow Jones Indices. This case discusses the index provider business model through the lenses of this transaction: sources of revenue and profitability, business valuation, uses of indexes in the m...Starting at €8.20
-
Professors Sven Larson and Kenneth Carpenter (E)
Heskett, James L.; Johannessen, Tor Askild AaseCase HBS-908412-EProf. Kenneth Carpenter has received word that he has inadvertently offended one of his students. He is pondering a possible response.Starting at €5.74
-
Warner Bros. Entertainment
Pisano, Gary P.; Wagonfeld, Alison BerkleyCase HBS-610036-EService and Operations ManagementExamines the process used by a major motion picture studio to develop and select movie projects. Warner Bros.' strategy is to focus its efforts on a small number of major "event" films (i.e., films with the potential to generate gross box-office receipts of $300 million or more). This strategy--which has worked for the past two years--entails risks. The studio is now asking how it can better manage these risks and, specifically, how it can improv...Starting at €8.20
-
Amyris Biotechnologies: Commercializing Biofuel
Pisano, Gary P.; Wagonfeld, Alison BerkleyCase HBS-610031-EService and Operations ManagementIn 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic biology to convert sugarcane into both renewable fuels and renewable chemicals. The Amyris' marketing team was investigating the commercial interest for both types of products, while the research and development team and the operations group were building processes that could accommodate both as well. CEO John Melo hoped to have commercial product available in 2011...Starting at €8.20
-
Dividend Policy at Linear Technology (Spanish version)
Baker, Malcolm P.; Wagonfeld, Alison BerkleyCase HBS-209S19FinanceIn 1992, Linear Technology, a designer and manufacturer of analog semiconductors, initiated a dividend. The firm increased its dividend by approximately $0.01 per share each year thereafter. In fiscal year 2002, Linear experienced its first significant drop in sales since its 1986 initial public offering. Sales dropped by 47%, and profits fell by 54%. In the spring of 2003, CFO Paul Coghlan is deciding whether to recommend yet another increase in...Starting at €8.20
-
Embrace
Chu, Michael; Bloom, David E.; Wagonfeld, Alison BerkleyCase HBS-814001-EEntrepreneurshipStarting at €8.20
-
Key Elements for Excellence in Classroom Cases and Teaching Notes
Austin, James E.; Heskett, James L.; Bartlett, Christopher A.Case HBS-915417-EThis document identifies the characteristics of excellent case studies and their accompanying teaching notes. The purpose is to provide guidance in preparing these educational vehicles. These guidelines were developed based on consultations with very experienced case teachers and an analysis of the elements of case studies and their teaching notes considered to be high quality by Harvard Business School faculty across departments, and on the ba...Starting at €8.20
-
Shouldice Hospital Limited B
Heskett, James L.; Hallowell, RogerCase HBS-913405-ESupplement for case 805002Starting at €8.20
-
Nanosolar, Inc.
Steenburgh, Thomas; Wagonfeld, Alison BerkleyCase HBS-510037-EMarketingNanosolar is a start-up company in the clean tech sector. It expects to be one of the first manufacturers to produce thin-film solar panels using copper indium gallium (di)selenide (CIGS) technology. Although this technology is less efficient in producing electricity than polysilicone, it is much less costly too. As it is about to enter the market, Nanosolar is facing the decision on which market to enter. Should it attempt to go into the Europea...Starting at €8.20
-
Shouldice Hospital B , Teaching Note
Heskett, James L.Teaching Note HBS-913407-ETeaching Note for 913405Starting at €0.00